CA2401295A1 - Process for preparing an anti viral medicinal product from plant extracts - Google Patents
Process for preparing an anti viral medicinal product from plant extracts Download PDFInfo
- Publication number
- CA2401295A1 CA2401295A1 CA002401295A CA2401295A CA2401295A1 CA 2401295 A1 CA2401295 A1 CA 2401295A1 CA 002401295 A CA002401295 A CA 002401295A CA 2401295 A CA2401295 A CA 2401295A CA 2401295 A1 CA2401295 A1 CA 2401295A1
- Authority
- CA
- Canada
- Prior art keywords
- virus
- compositions
- hepatitis
- hiv
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 229940121357 antivirals Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000419 plant extract Substances 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 208000030507 AIDS Diseases 0.000 abstract 3
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 241000700721 Hepatitis B virus Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000411851 herbal medicine Species 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000714177 Murine leukemia virus Species 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
This invention relates to compositions derived from Chinese herbal medicines, medicinal plans and extracts thereof, and to their use for the treatment of animals infected with viruses, especially with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). More specifically, the compositions of the present invention are derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption.
The compositions of the invention are obtained through specific techniques and have demonstrated outstanding efficacy tor treating human HBV carriers and hepatitis C patients. Compositions according to the invention have also exhibited in vitro antiviral activities against murine leukemia virus (MuL V) and HIV. HIV is the virus known to cause acquired immunodeficiency syndrome (AIDS) in humans and AIDS
presents special problem to the medical community which the present invention addresses.
The compositions of the invention are obtained through specific techniques and have demonstrated outstanding efficacy tor treating human HBV carriers and hepatitis C patients. Compositions according to the invention have also exhibited in vitro antiviral activities against murine leukemia virus (MuL V) and HIV. HIV is the virus known to cause acquired immunodeficiency syndrome (AIDS) in humans and AIDS
presents special problem to the medical community which the present invention addresses.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1610096P | 1996-07-09 | 1996-07-09 | |
| US60/016100 | 1996-07-09 | ||
| US2146796P | 1996-07-10 | 1996-07-10 | |
| US60/021467 | 1996-07-10 | ||
| CA002271622A CA2271622C (en) | 1996-07-09 | 1997-07-09 | Antiviral agents from plant extracts and use for treatment of viral infections |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002271622A Division CA2271622C (en) | 1996-07-09 | 1997-07-09 | Antiviral agents from plant extracts and use for treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2401295A1 true CA2401295A1 (en) | 1998-01-15 |
| CA2401295C CA2401295C (en) | 2008-01-29 |
Family
ID=27170967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002401295A Expired - Fee Related CA2401295C (en) | 1996-07-09 | 1997-07-09 | Process for preparing an anti viral medicinal product from plant extracts |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2401295C (en) |
-
1997
- 1997-07-09 CA CA002401295A patent/CA2401295C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2401295C (en) | 2008-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2271622A1 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
| WO2003063771A3 (en) | N4-acylcytosine nucleosides for treatment of viral iinfections | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| CA2165821A1 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
| EP1808434A3 (en) | Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B | |
| DK92788A (en) | USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA | |
| AU1226288A (en) | Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome | |
| CA2198010A1 (en) | 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent | |
| AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| CA2155020A1 (en) | Antiviral naphthoquinone compounds, compositions and uses thereof | |
| IL105169A0 (en) | Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv) | |
| CA2401295A1 (en) | Process for preparing an anti viral medicinal product from plant extracts | |
| WO1998001144A2 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
| DK720588A (en) | RELATIONSHIPS TO USE IN TREATMENT OR PREVENTION OF HUMAN IMMUNE INFECTIVE VIRUS (HIV) INFECTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME | |
| MY157594A (en) | Compositions of matter useful in the treatment of viral infections derived from plant extracts | |
| AP9600896A0 (en) | Anti-HIV triple combination. | |
| RU93058325A (en) | APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS | |
| EP0316592A3 (en) | 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application | |
| UA42693C2 (en) | The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus. | |
| EP0362755A3 (en) | Human cytotoxic t-cell clone and antibody thereto | |
| AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| HK1012567A1 (en) | Extracts of piliostigma thonningil the use thereof and formulations containing them | |
| AU3593095A (en) | Method of treatment of human immunodeficiency virus (hiv) infection | |
| TW217986B (en) | Compositions for the treatment of infection and disease caused by HBV | |
| AP9801368A0 (en) | Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |